On Tuesday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) was -1.91% drop from the session before settling in for the closing price of $1.57. A 52-week range for SLS has been $0.77 – $2.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 33.00%. With a float of $97.67 million, this company’s outstanding shares have now reached $99.78 million.
Let’s look at the performance matrix of the company that is accounted for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SELLAS Life Sciences Group Inc stocks. The insider ownership of SELLAS Life Sciences Group Inc is 2.11%, while institutional ownership is 14.33%. The most recent insider transaction that took place on May 30 ’25, was worth 33,800. In this transaction Director of this company bought 20,000 shares at a rate of $1.69, taking the stock ownership to the 30,400 shares. Before that another transaction happened on May 22 ’25, when Company’s Director bought 20,000 for $1.80, making the entire transaction worth $36,000. This insider now owns 41,000 shares in total.
SELLAS Life Sciences Group Inc (SLS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 33.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.68% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
You can see what SELLAS Life Sciences Group Inc (SLS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
SELLAS Life Sciences Group Inc (NASDAQ: SLS) saw its 5-day average volume 2.11 million, a negative change from its year-to-date volume of 2.44 million. As of the previous 9 days, the stock’s Stochastic %D was 9.56%. Additionally, its Average True Range was 0.14.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 54.31%, which indicates a significant increase from 4.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.32% in the past 14 days, which was lower than the 101.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4730, while its 200-day Moving Average is $1.2552.
